Elevated Asymmetric Dimethylarginine in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Preliminary Report

Elevated Asymmetric Dimethylarginine in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Preliminary Report

Background: Adult survivors of childhood malignancy are predisposed to late cardiovascular (CV) complications. Our aim was to estimate plasma levels of the endogenous nitric oxide formation inhibitor asymmetric dimethylarginine (ADMA), in long-term survivors of childhood acute lymphoblastic leukemia...

Full description

Bibliographic Details
Main Authors: Joanna Sulicka, Andrzej Surdacki, Magdalena Strach, Aleksander Kwater, Barbara Gryglewska, Magdalena Ćwiklińska, Walentyna Balwierz, Tomasz K. Grodzicki
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Disease Markers
Online Access:http://dx.doi.org/10.3233/DMA-2012-0906
id doaj-5504aad804ce44f4a64390862488c80c
record_format Article
spelling doaj-5504aad804ce44f4a64390862488c80c2020-11-24T22:40:40ZengHindawi LimitedDisease Markers0278-02401875-86302012-01-01332697610.3233/DMA-2012-0906Elevated Asymmetric Dimethylarginine in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Preliminary ReportJoanna Sulicka0Andrzej Surdacki1Magdalena Strach2Aleksander Kwater3Barbara Gryglewska4Magdalena Ćwiklińska5Walentyna Balwierz6Tomasz K. Grodzicki7Department of Internal Medicine and Gerontology, Faculty of Medicine, Jagiellonian University, Cracow, Poland2nd Department of Cardiology, Faculty of Medicine, Jagiellonian University, Cracow, PolandDepartment of Internal Medicine and Gerontology, Faculty of Medicine, Jagiellonian University, Cracow, PolandDepartment of Internal Medicine and Gerontology, Faculty of Medicine, Jagiellonian University, Cracow, PolandDepartment of Internal Medicine and Gerontology, Faculty of Medicine, Jagiellonian University, Cracow, PolandDepartment of Pediatric Oncology and Hematology, Polish-American Institute of Pediatrics, Faculty of Medicine, Jagiellonian University, Cracow, PolandDepartment of Pediatric Oncology and Hematology, Polish-American Institute of Pediatrics, Faculty of Medicine, Jagiellonian University, Cracow, PolandDepartment of Internal Medicine and Gerontology, Faculty of Medicine, Jagiellonian University, Cracow, PolandBackground: Adult survivors of childhood malignancy are predisposed to late cardiovascular (CV) complications. Our aim was to estimate plasma levels of the endogenous nitric oxide formation inhibitor asymmetric dimethylarginine (ADMA), in long-term survivors of childhood acute lymphoblastic leukemia (ALL) treated with only chemotherapy.http://dx.doi.org/10.3233/DMA-2012-0906
collection DOAJ
language English
format Article
sources DOAJ
author Joanna Sulicka
Andrzej Surdacki
Magdalena Strach
Aleksander Kwater
Barbara Gryglewska
Magdalena Ćwiklińska
Walentyna Balwierz
Tomasz K. Grodzicki
spellingShingle Joanna Sulicka
Andrzej Surdacki
Magdalena Strach
Aleksander Kwater
Barbara Gryglewska
Magdalena Ćwiklińska
Walentyna Balwierz
Tomasz K. Grodzicki
Elevated Asymmetric Dimethylarginine in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Preliminary Report
Disease Markers
author_facet Joanna Sulicka
Andrzej Surdacki
Magdalena Strach
Aleksander Kwater
Barbara Gryglewska
Magdalena Ćwiklińska
Walentyna Balwierz
Tomasz K. Grodzicki
author_sort Joanna Sulicka
title Elevated Asymmetric Dimethylarginine in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Preliminary Report
title_short Elevated Asymmetric Dimethylarginine in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Preliminary Report
title_full Elevated Asymmetric Dimethylarginine in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Preliminary Report
title_fullStr Elevated Asymmetric Dimethylarginine in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Preliminary Report
title_full_unstemmed Elevated Asymmetric Dimethylarginine in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Preliminary Report
title_sort elevated asymmetric dimethylarginine in young adult survivors of childhood acute lymphoblastic leukemia: a preliminary report
publisher Hindawi Limited
series Disease Markers
issn 0278-0240
1875-8630
publishDate 2012-01-01
description Background: Adult survivors of childhood malignancy are predisposed to late cardiovascular (CV) complications. Our aim was to estimate plasma levels of the endogenous nitric oxide formation inhibitor asymmetric dimethylarginine (ADMA), in long-term survivors of childhood acute lymphoblastic leukemia (ALL) treated with only chemotherapy.
url http://dx.doi.org/10.3233/DMA-2012-0906
work_keys_str_mv AT joannasulicka elevatedasymmetricdimethylarginineinyoungadultsurvivorsofchildhoodacutelymphoblasticleukemiaapreliminaryreport
AT andrzejsurdacki elevatedasymmetricdimethylarginineinyoungadultsurvivorsofchildhoodacutelymphoblasticleukemiaapreliminaryreport
AT magdalenastrach elevatedasymmetricdimethylarginineinyoungadultsurvivorsofchildhoodacutelymphoblasticleukemiaapreliminaryreport
AT aleksanderkwater elevatedasymmetricdimethylarginineinyoungadultsurvivorsofchildhoodacutelymphoblasticleukemiaapreliminaryreport
AT barbaragryglewska elevatedasymmetricdimethylarginineinyoungadultsurvivorsofchildhoodacutelymphoblasticleukemiaapreliminaryreport
AT magdalenacwiklinska elevatedasymmetricdimethylarginineinyoungadultsurvivorsofchildhoodacutelymphoblasticleukemiaapreliminaryreport
AT walentynabalwierz elevatedasymmetricdimethylarginineinyoungadultsurvivorsofchildhoodacutelymphoblasticleukemiaapreliminaryreport
AT tomaszkgrodzicki elevatedasymmetricdimethylarginineinyoungadultsurvivorsofchildhoodacutelymphoblasticleukemiaapreliminaryreport
_version_ 1725703942360268800

Similar Items